Active Biotech Ab Is A Biotechnology Company Based In Lundswedenfounded In 1983The Company Specializes In Immunologydeveloping Therapeutics For Cancerinflammatory Eye Disordersand Neurodegenerative Diseasesit Is Led By Ceo Helen Tuvessonwith Support From Cfo Hans Kolam And Cmo Drerik Vahtola Active Biotech Is Currently Advancing Several Products In Its Pipelinetasquinimod Is A Small Molecule Immunomodulator In Phase Ib Iia Trials For Multiple Myelomalaquinimod Targets Uveitis And Has Completed Phase I Trialsnaptumomab Is An Antibody Based Immunotherapy In Phase Ib Ii Studies For Solid Tumors And Lung Cancerthe Company Holds Patents And Applications For Its Therapies In The U S Japanand Europeactive Biotech Collaborates With Neotx Therapeutics Ltd And The Perelman School Of Medicine At The University Of Pennsylvaniaand It Has Conducted Over 20 Clinical Trials To Date
